How the stiffness of cell surroundings affects cell reprogramming
Regulation of cell reprogramming by matrix stiffness
This study looks at how the stiffness of the material around cells affects the process of turning skin cells into nerve cells, which could help improve treatments for various conditions in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10912474 on NIH RePORTER |
What this research studies
This research investigates how the stiffness of the extracellular matrix (the environment surrounding cells) influences the process of cell reprogramming, which is crucial for regenerative medicine and disease modeling. The study focuses on understanding the role of biophysical factors, particularly matrix stiffness, in regulating the conversion of fibroblasts into induced neuronal cells. By examining the interactions between matrix stiffness, actin assembly, and epigenetic changes, the research aims to identify optimal conditions for enhancing cell reprogramming efficiency. Patients may benefit from insights gained in this research for future therapies that utilize reprogrammed cells.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that could be treated through cell reprogramming, such as neurodegenerative diseases.
Not a fit: Patients with conditions unrelated to cell reprogramming or those who do not require regenerative therapies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for generating specialized cells for regenerative therapies.
How similar studies have performed: Previous research has shown promising results in understanding the role of biophysical factors in cell behavior, suggesting that this approach may yield significant insights.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Li, Song — University of California Los Angeles
- Study coordinator: Li, Song
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.